Stability of thiopental sodium and propofol in polypropylene syringes at 23 and 4 °C

American Journal of Health-System Pharmacy

Volumn 53, Issue 13, 1996, Pages 1576-1579

  Chernin, Eric L ^a   Stewart, James T ^b   Smiler, Barry ^a  

^a SARASOTA MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Additives; Anesthetics; Incompatibilities; Injections; Polypropylene; Propofol; St ability; Storage; Syringes; Temperature; Thiopental sodium

Indexed keywords

POLYPROPYLENE; PROPOFOL; THIOPENTAL;

ARTICLE; DRUG MIXTURE; DRUG STABILITY; DRUG STORAGE; ENVIRONMENTAL TEMPERATURE; FREEZING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; SYRINGE;

EID: 0029949080     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/53.13.1576     Document Type: Article

References (17)

1. Morrison DH. New iv induction anesthetics. Can J Anaesth. 1993; 40(5):r9-14.
2. Smith I, White P, Nathanson M et al. Propofol - an update on its clinical use. Anesthesiology. 1994; 81:1005-43.
3. Deegan RJ. Propofol: a review of the pharmacology and applications of an intravenous anesthetic agent. Am J Med Sci. 1992; 304(1):45-9.
4. Edelist G. A comparison of propofol and thiopentone as induction agents in outpatient surgery. Can J Anaesth. 1987; 34:110-6.
5. Kashtan H, Edelist G, Mallon J et al. Comparative evaluation of propofol and thiopentone foi total intravenous anesthesia. Can J Anaesth. 1990; 37:170-6.
6. Gold MI. Induction of anesthesia with propofol, thiopentone, and methohexital. Semin Anesth. 1988; 7(suppl 1):68-72.
7. Dexter F, Tinker J. Analysis of strategies to decrease postanesthesia care unit costs. Anesthesiology. 1995; 82:94-101.
8. Naguib M, Sari-Kouzal A, Thiopentone-propofol hypnotic synergism in patients. Br J Anaesth. 1991; 67:4-6.
9. Rashiq S, Gallant B, Grace M et al. Recovery characteristics following induction of anesthesia with a combination of thiopentone and propofol. Can J Anaesth. 1994; 41:1166-71.
10. Carr S, Waterman S, Rutherford G et al. Postsurgical infections associated with an extrinsically contaminated intravenous anesthetic agent - California, Illinois, Maine, and Michigan, 1990. MMWR. 1990; 39:426-7,433.
11. Sosis MB, Braverman B, Villaflor E. Propofol, but not thiopental, supports the growth of Candida albicans. Anesth Analg. 1995; 81:132-4.
12. Bennert SN, McNeil MM, Bland LA et al. Postoperative infections traced to contamination of an intravenous anesthetic, prapofol. N Engl J Med. 1995; 333:147-54.
13. Jarvis WR, Highsmith AK, Allen JR et al. Polymicrobial bacteremia associated with lipid emulsion in a neonatal intensive care unit. Pediatr Infect Dis. 1983; 2:202-8.
14. Wong CL, Warriner CB, McMormick JP et al. Reconstituted thiopentone retains its alkalinity without bacterial contamination for up to four weeks. Can J Anaesth. 1992; 39:504-8.
15. Wolin MJ, Miller TL. Bacterial anatomy, physiology and genetics. In: Freeman BA, ed. Burrows textbook of microbiology. 22nd ed. Philadelphia: Saunders; 1985:134.
16. Highsmith AK, Greenwood GP, Allen JR. Growth of nosocomial pathogens in multiple-dose parenteral medication vials. J Clin Microbiol. 1982; 15:1024-8.
17. Diprivan package insert. Wilmington, DE: Zeneca Pharmaceuticals; 1994 Oct.